Rocket Pharmaceuticals (RCKT) Misses Q1 EPS by 2c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q1 EPS of ($0.42), $0.02 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• BofA says convenience store sales trail broader retail channels
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• Northrop Grumman clears E-2D Hawkeye Block II design review